Formulation Of A Pan-species, Multi-stage Vaccine For The Malaria Eradication Agenda
Funder
National Health and Medical Research Council
Funding Amount
$777,611.00
Summary
GNT 1093311 entitled 'Formulation of a pan-species, multi-stage vaccine for the malaria eradication agenda' seeks to undertake the preclinical development of a saccharide conjugate vaccine directed towards all major species and stages of malaria. The objectives are: (i) to undertake the synthesis of the vaccine construct; (ii) to compare immunogenicity, formulation and efficacy of various vaccine constructs with a view to down-selecting the optimal combination to take to human clinical trial.